SXI Life Sciences
7.198,33
PKT
+45,74
PKT
+0,64
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.03.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.03.18 | Roche overweight | JP Morgan Chase & Co. | |
| 27.03.18 | Roche Underweight | Morgan Stanley | |
| 23.03.18 | Roche buy | Jefferies & Company Inc. | |
| 21.03.18 | Roche Hold | Deutsche Bank AG | |
| 20.03.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.03.18 | Roche Neutral | UBS AG | |
| 20.03.18 | Roche overweight | JP Morgan Chase & Co. | |
| 14.03.18 | Novartis buy | Société Générale Group S.A. (SG) | |
| 14.03.18 | Roche Sell | Société Générale Group S.A. (SG) | |
| 02.03.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 02.03.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.03.18 | Novartis Neutral | UBS AG | |
| 26.02.18 | Novartis buy | Jefferies & Company Inc. | |
| 26.02.18 | Roche buy | Jefferies & Company Inc. | |
| 22.02.18 | Novartis buy | Société Générale Group S.A. (SG) | |
| 20.02.18 | Novartis Underweight | Barclays Capital | |
| 20.02.18 | Roche Hold | Kepler Cheuvreux | |
| 20.02.18 | Roche Neutral | UBS AG | |
| 16.02.18 | Novartis buy | Baader Bank | |
| 12.02.18 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 09.02.18 | Novartis buy | Kepler Cheuvreux | |
| 06.02.18 | Roche Neutral | UBS AG | |
| 06.02.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.02.18 | Roche overweight | JP Morgan Chase & Co. | |
| 05.02.18 | Roche overweight | Barclays Capital | |
| 05.02.18 | Roche Hold | Deutsche Bank AG | |
| 02.02.18 | Roche overweight | JP Morgan Chase & Co. | |
| 02.02.18 | Roche kaufen | DZ BANK | |
| 02.02.18 | Roche Outperform | Bernstein Research | |
| 01.02.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.01.18 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.01.18 | Novartis overweight | Morgan Stanley | |
| 25.01.18 | Novartis Hold | Deutsche Bank AG | |
| 25.01.18 | Novartis Hold | S&P Capital IQ | |
| 25.01.18 | Novartis Underweight | Barclays Capital | |
| 25.01.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 24.01.18 | Novartis Neutral | Credit Suisse Group | |
| 25.01.18 | Novartis Underperform | Credit Suisse Group | |
| 24.01.18 | Novartis buy | Kepler Cheuvreux |